Clinical Trial Update: Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Coronary Angiography [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing two iodinated contrast media in patients at risk undergoing coronary angiography to evaluate renal effects; the study has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Coronary Artery Disease

Drugs mentioned

• Iodinated contrast media A
• Iodinated contrast media B

Snippet

Sponsor: GE Healthcare | Conditions: Coronary Artery Disease, Renal Impairment | Phase 4 | Status: COMPLETED